BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1070 related articles for article (PubMed ID: 25769245)

  • 1. Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration.
    Schütze C; Wedl M; Baumann B; Pircher M; Hitzenberger CK; Schmidt-Erfurth U
    Am J Ophthalmol; 2015 Jun; 159(6):1100-1114.e1. PubMed ID: 25769245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Macular Atrophy Detected by Fundus Autofluorescence in Patients With Neovascular Age-Related Macular Degeneration After Long-Term Ranibizumab Treatment.
    Kuehlewein L; Dustin L; Sagong M; Hariri A; Mendes TS; Rofagha S; Bhisitkul RB; Sadda SR
    Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):224-31. PubMed ID: 26985795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C
    Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outer retinal corrugations in age-related macular degeneration.
    Ooto S; Vongkulsiri S; Sato T; Suzuki M; Curcio CA; Spaide RF
    JAMA Ophthalmol; 2014 Jul; 132(7):806-13. PubMed ID: 24801396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal Pigment Epithelial Atrophy in Neovascular Age-Related Macular Degeneration After Ranibizumab Treatment.
    Kuroda Y; Yamashiro K; Tsujikawa A; Ooto S; Tamura H; Oishi A; Nakanishi H; Miyake M; Yoshikawa M; Yoshimura N
    Am J Ophthalmol; 2016 Jan; 161():94-103.e1. PubMed ID: 26432927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of choroidal and retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
    Young M; Chui L; Fallah N; Or C; Merkur AB; Kirker AW; Albiani DA; Forooghian F
    Retina; 2014 Jul; 34(7):1308-15. PubMed ID: 24451923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study.
    Clemens CR; Wolf A; Alten F; Milojcic C; Heiduschka P; Eter N
    Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.
    Nagiel A; Freund KB; Spaide RF; Munch IC; Larsen M; Sarraf D
    Am J Ophthalmol; 2013 Nov; 156(5):981-988.e2. PubMed ID: 23972309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geographic atrophy in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
    Xu L; Mrejen S; Jung JJ; Gallego-Pinazo R; Thompson D; Marsiglia M; Freund KB
    Retina; 2015 Feb; 35(2):176-86. PubMed ID: 25387047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
    Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study.
    Spooner KL; Fraser-Bell S; Cozzi M; Staurenghi G; Invernizzi A; Monteduro D; Munk MR; Hong T; Chang AA
    Ophthalmology; 2020 Dec; 127(12):1663-1673. PubMed ID: 32544561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal pigment epithelial characteristics in eyes with neovascular age-related macular degeneration : Long-term retinal changes under anti-vascular endothelial growth factor treatment.
    Ebner C; Wernigg C; Schütze C; Weingessel B; Vécsei-Marlovits PV
    Wien Klin Wochenschr; 2021 Feb; 133(3-4):123-130. PubMed ID: 32761460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectral-Domain OCT-Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
    Gune S; Abdelfattah NS; Karamat A; Balasubramanian S; Marion KM; Morgenthien E; Sadda SR
    Ophthalmology; 2020 Apr; 127(4):523-532. PubMed ID: 31718842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
    Sadda SR; Tuomi LL; Ding B; Fung AE; Hopkins JJ
    Ophthalmology; 2018 Jun; 125(6):878-886. PubMed ID: 29477692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change of retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in exudative age-related macular degeneration.
    Kim M; Kim ES; Seo KH; Yu SY; Kwak HW
    Indian J Ophthalmol; 2016 Jun; 64(6):427-33. PubMed ID: 27488150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy.
    Sayegh RG; Simader C; Scheschy U; Montuoro A; Kiss C; Sacu S; Kreil DP; Prünte C; Schmidt-Erfurth U
    Ophthalmology; 2011 Sep; 118(9):1844-51. PubMed ID: 21496928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial.
    Abdelfattah NS; Al-Sheikh M; Pitetta S; Mousa A; Sadda SR; Wykoff CC;
    Ophthalmology; 2017 Feb; 124(2):215-223. PubMed ID: 27863845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
    Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical Coherence Tomography Features Preceding the Onset of Advanced Age-Related Macular Degeneration.
    Ferrara D; Silver RE; Louzada RN; Novais EA; Collins GK; Seddon JM
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3519-3529. PubMed ID: 28715590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.